Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases SC Katz, RA Burga, E McCormack, LJ Wang, W Mooring, GR Point, ... Clinical cancer research 21 (14), 3149-3159, 2015 | 421 | 2015 |
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T RA Burga, M Thorn, GR Point, P Guha, CT Nguyen, LA Licata, ... Cancer Immunology, Immunotherapy 64, 817-829, 2015 | 227 | 2015 |
A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration NT Khanarian, NM Haney, RA Burga, HH Lu Biomaterials 33 (21), 5247-5258, 2012 | 180 | 2012 |
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma J Cano-Mejia, RA Burga, EE Sweeney, JP Fisher, CM Bollard, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (2), 771-781, 2017 | 126 | 2017 |
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma ES Yvon, R Burga, A Powell, CR Cruz, R Fernandes, C Barese, T Nguyen, ... Cytotherapy 19 (3), 408-418, 2017 | 113 | 2017 |
Engineering the TGFβ receptor to enhance the therapeutic potential of natural killer cells as an immunotherapy for neuroblastoma RA Burga, E Yvon, E Chorvinsky, R Fernandes, CRY Cruz, CM Bollard Clinical Cancer Research 25 (14), 4400-4412, 2019 | 61 | 2019 |
Beyond CAR T cells: other cell-based immunotherapeutic strategies against cancer S Patel, RA Burga, AB Powell, EA Chorvinsky, N Hoq, SE McCormack, ... Frontiers in oncology 9, 196, 2019 | 58 | 2019 |
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma J Miska, A Rashidi, C Lee-Chang, P Gao, A Lopez-Rosas, P Zhang, ... Science Advances 7 (8), eabc8929, 2021 | 50 | 2021 |
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma C Lee-Chang, J Miska, D Hou, A Rashidi, P Zhang, RA Burga, ... Journal of Experimental Medicine 218 (1), e20200913, 2020 | 45 | 2020 |
Neutrophil: lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases A Saied, L Licata, RA Burga, M Thorn, E McCormack, BF Stainken, ... Cancer gene therapy 21 (11), 457-462, 2014 | 44 | 2014 |
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization AB Powell, S Yadavilli, D Saunders, S Van Pelt, E Chorvinsky, RA Burga, ... Journal of Translational Medicine 17, 1-10, 2019 | 40 | 2019 |
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy RA Burga, S Patel, CM Bollard, CR Y Cruz, R Fernandes Nanomedicine 11 (14), 1759-1767, 2016 | 39 | 2016 |
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils LA Licata, CT Nguyen, RA Burga, V Falanga, NJ Espat, A Ayala, M Thorn, ... Journal of Leukocyte Biology 94 (4), 813-823, 2013 | 39 | 2013 |
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells RA Burga, T Nguyen, J Zulovich, S Madonna, L Ylisastigui, R Fernandes, ... Cytotherapy 18 (11), 1410-1421, 2016 | 36 | 2016 |
Composite iron oxide–Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors SS Kale, RA Burga, EE Sweeney, Z Zun, RW Sze, A Tuesca, ... International Journal of Nanomedicine, 6413-6424, 2017 | 30 | 2017 |
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors EE Sweeney, RA Burga, C Li, Y Zhu, R Fernandes Scientific Reports 6 (1), 37035, 2016 | 30 | 2016 |
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor SC Katz, RA Burga, S Naheed, LA Licata, M Thorn, D Osgood, ... Journal of translational medicine 11, 1-10, 2013 | 30 | 2013 |
Designing magnetically responsive biohybrids composed of cord blood-derived natural killer cells and iron oxide nanoparticles RA Burga, DH Khan, N Agrawal, CM Bollard, R Fernandes Bioconjugate chemistry 30 (3), 552-560, 2019 | 26 | 2019 |
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function EE Sweeney, PB Balakrishnan, AB Powell, A Bowen, I Sarabia, RA Burga, ... Nano research 13, 736-744, 2020 | 17 | 2020 |
An Engineered Prussian Blue Nanoparticles‐Based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH‐MYCN Neuroblastoma Model A Shukla, J Cano-Mejia, J Andricovich, RA Burga, EE Sweeney, ... Advanced nanobiomed research 1 (8), 2100021, 2021 | 15 | 2021 |